Annual report pursuant to Section 13 and 15(d)

Warrants (Tables)

v3.23.1
Warrants (Tables)
12 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Outstanding Warrants and Changes in Fair Value
The following summarizes the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the years ended December 31, 2022 and 2021:
Warrants Weighted Average Exercise Price
Warrants outstanding as of December 31, 2020 9,916,997  $ 7.32 
Issued 548,110  $ 8.70 
Exercised (389,881) $ 4.52 
Terminated/Expired (641,642) $ 24.64 
Warrants outstanding as of December 31, 2021 9,433,584  $ 5.92 
Issued —  $ — 
Exercised —  $ — 
Terminated/Expired —  $ — 
Warrants outstanding as of December 31, 2022 9,433,584  $ 5.92 
The following schedule shows the change in fair value during the year ended December 31, 2021 (in thousands):
Warrant liability
Balance as of December 31, 2020 $ 39,850 
Change in fair value of warrant liability (23,463)
Reclassification of warrant liability to equity (1)
(16,387)
Balance as of December 31, 2021 $ — 
(1)Reclassified to equity on July 1, 2021 in connection with the IPO. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information.
Schedule of Fair Value Measurement Inputs
The following schedule shows the inputs used to measure the fair value of the warrant liability:
Warrant Liability July 1, 2021
Stock Price $4.19
Exercise Price $4.50
Expected remaining term (in years)
5.25 - 5.31
Volatility 60.0%
Risk-free interest rate 0.94%